http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 20 Jul 2026 08:20:54 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Management+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html <p>Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026, according to a company statement.</p> <p>Malarek currently serves as CEO of Foundation Medicine Inc., an independent affiliate of the Roche Group. He joined Roche in 2007 and has held various leadership roles within the company, including Head of Marketing and Business Development in Diabetes Care, Lifecycle Leader in Molecular Diagnostics, General Manager of Roche Diagnostics Norway, and Global Head of Marketing and Customer Insights for Roche Diagnostics.</p> <p>Malarek will succeed Brad Moore, who is retiring at the http://www.streetinsider.com/Hot+Mgmt+Changes/Roche+names+new+diagnostics+North+America+chief%2C+effective+Aug.+1/26787438.html Mon, 20 Jul 2026 08:20:54 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html <div class="xn-content"> <ul type="disc"><li><b><person>Dan Malarek</person>, current CEO of <span value="ACORN:3923618108" idsrc="xmltag.org" >Foundation Medicine Inc.</span>, appointed President and CEO of <span>Roche Diagnostics North America</span>, effective <chron>August 1, 2026</chron></b></li><li><b>Malarek succeeds <person>Brad Moore</person>, who will retire at the end of July following nearly a decade of distinguished service at <span value="Swiss:RO" idsrc="xmltag.org">Roche</span></b></li><li><b><person>Antonio Vergara</person> appointed Chief Commercial Officer to lead <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial business units</b></li></ul><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734184-1&amp;h=1695720901&amp;u=https%3A%2F%2Fdiagnostics.roche.com%2Fus%2Fen%2Fnews-listing%2F2026%2Fdan-malarek-appointed-ceo-roche-diagnostics-north-america.html&amp;a=Roche" target="_blank" rel="nofollow"><span value="Swiss:RO" idsrc="xmltag.org">Roche</span></a> (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of <person>Dan Malarek</person> as President and CEO of <span>Roche Diagnostics North America</span>, effective http://www.streetinsider.com/Press+Releases/Roche+Appoints+Dan+Malarek+as+President+and+CEO+of+Roche+Diagnostics+North+America/26787437.html Mon, 20 Jul 2026 08:20:00 -0400 A.08801724 A.39236181 O.00222322 O.00268852 O.08637363 RHHBY RO RO ROP